Xenon Pharmaceuticals Inc.
XENE
$42.88
-$0.63-1.45%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 462.27M | 487.55M | 549.63M | 626.91M | 654.02M |
| Total Receivables | 812.00K | 1.10M | 8.65M | 1.47M | 938.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.06M | 11.61M | 7.26M | 6.89M | 4.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 480.14M | 500.25M | 565.54M | 635.26M | 659.64M |
|
|
|||||
| Total Current Assets | 480.14M | 500.25M | 565.54M | 635.26M | 659.64M |
| Net Property, Plant & Equipment | 15.85M | 16.50M | 17.31M | 18.22M | 18.42M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.86M | 20.24M | 18.93M | 17.16M | 8.53M |
| Total Assets | 607.84M | 674.28M | 743.28M | 798.14M | 835.90M |
|
|
|||||
| Total Accounts Payable | 4.55M | 4.79M | 6.88M | 5.07M | 5.43M |
| Total Accrued Expenses | 32.06M | 24.97M | 17.21M | 23.47M | 21.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.50M | 1.46M | 1.38M | 1.37M | 1.39M |
| Total Finance Division Other Current Liabilities | 231.00K | 1.83M | 6.56M | 5.69M | 1.08M |
| Total Other Current Liabilities | 231.00K | 1.83M | 6.56M | 5.69M | 1.08M |
| Total Current Liabilities | 38.34M | 33.05M | 32.03M | 35.59M | 29.70M |
|
|
|||||
| Total Current Liabilities | 38.34M | 33.05M | 32.03M | 35.59M | 29.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.83M | 7.26M | 7.29M | 7.65M | 8.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.16M | -- | -- | -- | -- |
| Total Liabilities | 48.33M | 40.30M | 39.32M | 43.24M | 38.09M |
|
|
|||||
| Common Stock & APIC | 1.70B | 1.68B | 1.67B | 1.66B | 1.63B |
| Retained Earnings | -1.14B | -1.05B | -964.52M | -899.47M | -833.79M |
| Treasury Stock & Other | 477.00K | 113.00K | -836.00K | -1.61M | 1.34M |
| Total Common Equity | 559.51M | 633.98M | 703.96M | 754.90M | 797.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 559.51M | 633.98M | 703.96M | 754.90M | 797.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 559.51M | 633.98M | 703.96M | 754.90M | 797.81M |
|
|
|||||